// App-Quantinova.ai

SAT0103 : THE EFFECT OF BODYWEIGHT ON RESPONSE TO INTRAVENOUS OR SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS

Researchers

Presenter

  • R. Davies

Principal Investigators

  • A. Vivekanantham

  • M. Lunt

  • K. Watson

  • K. Hyrich

  • J. Bluett

Medical Centers

  • The University of Manchester, Centre for Epidemiology Versus Arthritis, M13 9PT, United Kingdom

  • Manchester Academic Health Science, National Institute of Health Research Musculoskeletal Biomedical Research Centre, Manchester, United Kingdom

  • The University of Manchester, Arthritis Research UK Centre for Genetics and Genomics, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Body mass index

Drug/Treatment

  • Tocilizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Pfizer

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved